ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,090, issued on March 17.
"Oral brexanolone compositions and methods of preparation and use" was invented by Nachiappan Chidambaram (Salt Lake City), Mahesh V. Patel (Salt Lake City), Jonathan Ogle (Salt Lake City), Kongnara Papangkorn (Salt Lake City), Samuel Akapo (Salt Lake City), Joel Frank (Salt Lake City) and Benjamin J. Bruno (Salt Lake City).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method and a brexanolone containing oral composition for treating CNS disorders such as depression. An embodiment of the invention comprises orally administering a brexanolone containing composition to a subject having a CNS disorder. The compo...